605177.SS · 东亚药业
China A-shares · RS rating 98 · As of 2026-10-14
| Price | 24.13 CNY |
|---|---|
| 1-day change | -2.7% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 97 / 97 / 86 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 49 / 53 / 46 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -23.8% |
| Distance from 52-week high | +14.7% |
| Market cap (USD) | $441.2M |